Google has announced a significant policy change affecting healthcare and pharmaceutical advertisers. Starting in July 2025, any advertiser that employs personalized targeting methods using restricted drug-related terms will be required to obtain certification from the platform.
The move is part of Google’s ongoing effort to enhance transparency and user protection within its advertising ecosystem. Personalized advertising—which includes targeting users based on personal characteristics, web activity, or inferred interests—can be particularly sensitive when it involves healthcare topics and pharmaceutical content.
Restricted drug terms typically include references to prescription medications, treatments for specific conditions, and certain medical procedures. Without proper oversight, the personalized promotion of such content poses ethical concerns and potential risks to user privacy and well-being.
According to Google, the new certification process will allow the platform to ensure that advertisers using these terms meet strict policy and regulatory compliance standards. Certified advertisers will be required to verify their healthcare credentials and demonstrate responsible use of targeting tools. Non-certified advertisers attempting to use these tactics may be subject to account restrictions or removal from the platform.
This policy update builds on Google’s previous efforts to regulate sensitive ad content, such as limiting targeting related to personal hardship, health conditions, and alcohol. The introduction of this new certification requirement aims to support user autonomy and trust, while enabling legitimate healthcare providers to continue responsibly promoting their services.
Advertisers impacted by the change are encouraged to begin preparations now by reviewing Google’s advertising policies and certification application processes. More detailed guidelines and instructions will be released by Google ahead of the July 2025 enforcement date.
Source: https:// – Courtesy of the original publisher.
